Core Scientific, Inc. (CORZ) financial statements and ratios from SEC XBRL: revenue $319.02M (TTM), net margin -90.5%, revenue growth 108.8% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $319.02M |
| Net Margin | -90.5% |
| Revenue Growth (YoY) | 108.8% |
| EPS Growth (YoY) | 8200.0% |
| FCF Growth (YoY) | 569.1% |
| Price / Sales | 13.51 |
| FCF Yield | -16.1% |
| Altman Z-Score | -1.57 (distress) |
| Sector P/E (Financials) | 15.1 |
CORZ overview · CORZ earnings · CORZ KPIs · CORZ investor relations · CORZ ownership · CORZ peers · CORZ filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.